A Study of Metformin in Patients with Li-Fraumeni Syndrome
The Center for Cancer Research, National Cancer Institute, is now accepting participants for a pilot study evaluating the effects of Metformin in patients with LFS. Metformin is currently being studied in over sixty clinical trials of cancers including breast, colon, and uterine cancer, among others. This is the first study in patients with Li-Fraumeni Syndrome